Nebulized-swallowed albuterol for the treatment of food impaction in pediatric patients with eosinophilic esophagitis: A novel nonendoscopic approach

Authors

• Thirumazhisai S. Gunasekaran, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA.
• Kiranmai Gorla, Advocate Health - MidwestFollow
• James Berman, Advocate Health - MidwestFollow
• Vrinda Bhardwaj, Children's Hospital of Los Angeles, University of Southern California, Los Angeles, CA.

Recommended Citation

Gunasekaran TS, Gorla K, Berman J, Bhardwaj V. Nebulized-Swallowed Albuterol for the Treatment of Food Impaction in Pediatric Patients with Eosinophilic Esophagitis: A Novel Nonendoscopic Approach. J Pediatr Clin Pract. 2026;20:200212. Published 2026 Apr 20. doi:10.1016/j.jpedcp.2026.200212

Affiliations

Advocate Children's Hospital Park Ridge

Abstract

Food impaction (FI) is a manifestation of eosinophilic esophagitis (EoE) and requires endoscopic removal. We report the response to nebulized albuterol in 5 children with EoE and FI. Albuterol (2.5 mg/3 mL) was administered via nebulizer, with instructions to breathe and swallow the aerosol condensate. Four of 5 patients experienced relief of the impaction. Endoscopy with biopsies performed acutely in 1 patient and subsequently in the others confirmed EoE in all patients. This technique represents a novel approach for the nonendoscopic management of FI in EoE.

Type

Article

PubMed ID

42206241